iTeos to Present at the 41st Annual J.P. Morgan Healthcare Conference
CAMBRIDGE, Mass. and GOSSELIES, Belgium, Jan. 03, 2023 (GLOBE NEWSWIRE) -- iTeos Therapeutics, Inc. (Nasdaq: ITOS), a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of immuno-oncology therapeutics for patients, today announced that Michel Detheux, Ph.D., President and Chief Executive Officer, will present at the 41st Annual J.P. Morgan Conference being held in San Francisco, CA on Tuesday, January 10, 2023 at 8:15 a.m. PST (11:15 a.m. EST).
A live webcast of the presentation will be available on the Investors section of the company’s website at https://www.iteostherapeutics.com. An archived replay will be available for approximately 30 days following the presentation.
About iTeos Therapeutics, Inc.
iTeos Therapeutics is a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation immuno-oncology therapeutics for patients. iTeos Therapeutics leverages its deep understanding of tumor immunology and immunosuppressive pathways to design novel product candidates with the potential to fully restore the immune response against cancer. The Company’s innovative pipeline includes two clinical-stage programs targeting novel, validated immuno-oncology pathways designed with optimized pharmacologic properties for improved clinical outcomes. The first antibody product candidate, EOS-448, is a high affinity, potent, anti-TIGIT antibody with a functional Fc domain, designed to enhance the anti-tumor response through a multifaceted immune modulatory mechanism, currently progressing in multiple indications in collaboration with GSK. The Company is also advancing inupadenant, a next-generation adenosine A2A receptor antagonist tailored to overcome cancer immunosuppression into proof-of-concept trials in several indications following encouraging single-agent activity in Phase 1. iTeos Therapeutics is headquartered in Watertown, MA with a research center in Gosselies, Belgium.
Internet Posting of Information
iTeos routinely posts information that may be important to investors in the 'Investors' section of its website at www.iteostherapeutics.com. The company encourages investors and potential investors to consult our website regularly for important information about iTeos.
For further information, please contact:
Investor Contacts:
Ryan Baker
iTeos Therapeutics, Inc.
Ryan.Baker@iteostherapeutics.com
Media Contacts:
media@iteostherapeutics.com
To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
GlobeNewswire by notifiedGlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Holding(s) in Company11.12.2023 18:11:50 CET | Press release
TORONTO, Canada, Dec. 11, 2023 (GLOBE NEWSWIRE) -- TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:Amaroq Minerals Ltd.1b. Please indicate if the issuer is a non-UK issuer (please mark with an “X” if appropriate)Non-UK issuerX2. Reason for the notification (please mark the appropriate box or boxes with an “X”)An acquisition or disposal of voting rightsXAn acquisition or disposal of financial instrumentsAn event changing the breakdown of voting rightsOther (please specify):3. Details of person subject to the notification obligationNameAkta sjóðir hf., an alternative investment fund manager and a UCITC management company, acting on behalf of funds operated by the company.City and country of registered office (if applicable)Reykjavík, Iceland4. Full name of sha
Carbios praised by French President at two-year anniversary of France 203011.12.2023 18:00:00 CET | Press release
PRESS RELEASE Carbios praised by French President at two-year anniversary of France 2030 Clermont-Ferrand (France), December 11, 2023 (6:00 PM CET). Carbios (Euronext Growth Paris: ALCRB), a pioneer in the development and industrialization of biological technologies to reinvent the life cycle of plastic and textiles, was one of eight beneficiaries selected to present the progress of its industrial project in the presence of the President of the French Republic on the occasion of the two-year anniversary of the launch of the France 2030 investment plan. Carbios is receiving €42.5 million in public funding (€30 million from the State as part of France 2030 and €12.5 million from the Grand-Est Region) for the construction of the world's first plant for the enzymatic depolymerization of PET. Carbios is an emblematic example of the France 2030 initiative to support innovative projects that contribute to reindustrialization through innovation in strategic sectors, such as recycling. This pla
HMS Networks förvärvar Red Lion Controls och utökar sin närvaro i Nordamerika väsentligt11.12.2023 18:00:00 CET | Pressemelding
DETTA PRESSMEDDELANDE ÄR INTE OCH UTGÖR INTE EN DEL AV NÅGOT ERBJUDANDE ATT FÖRVÄRVA VÄRDEPAPPER. KOPIOR AV DETTA MEDDELANDE FÅR INTE GÖRAS I OCH FÅR INTE DISTRIBUERAS ELLER SKICKAS TILL USA, AUSTRALIEN, KANADA, JAPAN, SYDAFRIKA, NYA ZEELAND, HONGKONG, SINGAPORE ELLER NÅGON ANNAN JURISDIKTION DÄR DISTRIBUTIONEN AV DETTA PRESSMEDDELANDE SKULLE VARA I STRID MED GÄLLANDE REGLER ELLER KRÄVA REGISTRERING ELLER ANDRA ÅTGÄRDER. HMS Networks AB (publ) (“HMS”), en global leverantör av industriell informations- och kommunikationsteknologi, har idag ingått ett bindande avtal med Spectris Group Holdings Limited om att förvärva Red Lion Controls, en väletablerad leverantör av industriella automationslösningar baserad i USA, genom att förvärva 100 procent av aktierna i Red Lion Controls Inc. och Red Lion Europe GmbH samt vissa tillgångar i andra jurisdiktioner ("Red Lion"), vilket väsentligt utökar HMS närvaro på den nordamerikanska marknaden och kompletterar HMS erbjudande. Förvärvet i korthet HMS
HMS Networks acquires Red Lion Controls and significantly expands its presence in North America11.12.2023 18:00:00 CET | Press release
THIS PRESS RELEASE IS NOT AND DOES NOT FORM A PART OF ANY OFFER FOR SALE OF SECURITIES. COPIES OF THIS COMMUNICATION MAY NOT BE MADE IN, AND MAY NOT BE DISTRIBUTED TO OR SENT INTO, THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA, NEW ZEALAND, HONG KONG, SINGAPORE, OR ANY OTHER JURISDICTION IN WHICH DISTRIBUTION OF THIS PRESS RELEASE WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR OTHER MEASURES. HMS Networks AB (publ) (“HMS”), a global provider of industrial information and communication technology, has today entered into a binding agreement with Spectris Group Holdings Limited to acquire the Red Lion Controls business, a well-established US-based provider of industrial automation solutions, through the acquisition of 100 percent of the shares in Red Lion Controls Inc. and Red Lion Europe GmbH as well as certain assets in other jurisdictions (“Red Lion”), significantly expanding HMS’ presence in the North American market and complementing HMS’ offering. Summary of the acqu
Iveco Group: periodic report on the buyback program11.12.2023 17:50:00 CET | Press release
Turin, 11th December 2023. Iveco Group N.V. (EXM: IVG) announces that, under the ongoing initial tranche of the common share buyback program announced on 14th April 2023, the Company completed on a daily basis, starting from 4th December 2023 to 8th December 2023 the following transactions: DateNumber of repurchased Common SharesAverage net price (euro)Total net consideration (euro)4 December 202336,0007.6118274,025.345 December 202336,0007.7060277,414.386 December 202335,0007.8616275,157.067 December 202334,5007.9324273,666.398 December 202335,2007.9369279,378.57Total176,7007.80781,379,641.73 An overall overview of the purchases carried out under the current share buyback program as well as the details of the above transactions, are available on the Company’s corporate website at the following address: https://www.ivecogroup.com/investors/stock_information/share_buyback. Iveco Group N.V. (EXM: IVG) is the home of unique people and brands that power your business and mission to advance